(Q46035311)

18 December 2017

title

Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. (English)

1 reference

18 December 2017

cytomegalovirus retinitis

main subject

Cytomegalovirus

0 references

1 reference

J B Reed

1

1 reference

18 December 2017

I R Schwab

series ordinal

2

1 reference

18 December 2017

J Gordon

series ordinal

3

1 reference

18 December 2017

L S Morse

series ordinal

4

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

18 December 2017

American Journal of Ophthalmology

published in

1 reference

18 December 2017

volume

124

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

199-205

1 reference

18 December 2017

Natural history of untreated cytomegalovirus retinitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Protease inhibitors for HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Advances in the management of AIDS-related cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Changing the natural history of HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

Atypical retinitis in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970784-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(14)70784-6

1 reference

18 December 2017

1 reference

18 December 2017